CD274 and breast carcinoma: Taken together, our experiments suggest that autophagy inhibition in tumors combined with immunoadjuvants and an anti-PD-L1 antibody can enhance immunotherapy of advanced breast cancer, delay tumor growth, and prevent recurrence.